Last reviewed · How we verify
Buprenorphine and Norbuprenorphine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Buprenorphine and Norbuprenorphine (Buprenorphine and Norbuprenorphine) — ViiV Healthcare.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Buprenorphine and Norbuprenorphine TARGET | Buprenorphine and Norbuprenorphine | ViiV Healthcare | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Buprenorphine and Norbuprenorphine CI watch — RSS
- Buprenorphine and Norbuprenorphine CI watch — Atom
- Buprenorphine and Norbuprenorphine CI watch — JSON
- Buprenorphine and Norbuprenorphine alone — RSS
Cite this brief
Drug Landscape (2026). Buprenorphine and Norbuprenorphine — Competitive Intelligence Brief. https://druglandscape.com/ci/buprenorphine-and-norbuprenorphine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab